Hyundai Bioscience to launch clinical trial of Polytaxel in pancreatic cancer

By NS Healthcare Staff Writer

28 Nov 22

The South Korean biotech firm claimed that the anticancer therapy candidate could complete chemotherapy with two doses in…

Clinical trialsPharmaceuticals

Investigational mRNA vaccine shows promise against all 20 flu strains

By NS Healthcare Staff Writer

25 Nov 22

The two-dose vaccine, which leverages the same mRNA technology used in the Covid-19 vaccines developed by Pfizer and…

PharmaceuticalsClinical trials

Astellas unveils positive results for Zolbetuximab from Phase 3 SPOTLIGHT trial

By NS Healthcare Staff Writer

17 Nov 22

Zolbetuximab is an investigational monoclonal antibody that targets Claudin 18.2 and is used for the treatment of CLDN18.2-positive,…

PharmaceuticalsClinical trials

Emergent wins US government research award to study Chikungunya vaccine

By NS Healthcare Staff Writer

15 Nov 22

The company will initiate a post-approval efficacy study in areas with active chikungunya virus (CHIKV) transmission, in collaboration…

PharmaceuticalsClinical trials

Bristol Myers unveils positive results for Reblozyl from Phase 3 COMMANDS study

By NS Healthcare Staff Writer

01 Nov 22

The study evaluated the efficacy and safety of Reblozyl in treating anaemia due to very low-, low- or…

PharmaceuticalsClinical trials

Novavax gets FDA EUA for COVID-19 Vaccine, Adjuvanted as booster for adults

By NS Healthcare Staff Writer

20 Oct 22

The FDA Emergency Use Authorisation decision was based on the findings of the phase 3 Prevent-19 clinical trial…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

GSK’s PERLA phase 2 trial of dostarlimab meets primary endpoint

By NS Healthcare Staff Writer

06 Oct 22

The mid-stage trial is a randomised, double-blind study featuring 243 patients with metastatic non-squamous NSCLC who met certain…

PharmaceuticalsClinical trials

Eisai and Biogen’s lecanemab meets primary endpoint in phase 3 AD trial

By NS Healthcare Staff Writer

28 Sep 22

The phase 3 confirmatory Clarity AD clinical trial of lecanemab also met all key secondary endpoints, while delivering…

Clinical trialsPharmaceuticals

Pfizer, Sangamo re-open recruitment for giroctocogene fitelparvovec phase 3 study

By NS Healthcare Staff Writer

23 Sep 22

The patient dosing with the haemophilia A gene therapy candidate is expected to start in October 2022 in…

PharmaceuticalsClinical trials

Sandoz’ denosumab biosimilar candidate meets objectives of ROSALIA study

By NS Healthcare Staff Writer

19 Sep 22

The trial showed that the proposed biosimilar matched the reference product on the basis of pharmacokinetics, efficacy, pharmacodynamics,…

PharmaceuticalsClinical trials